home / stock / bway / bway news

BWAY News and Press, BrainsWay Ltd. From 11/03/22

Stock Information
Company Name: BrainsWay Ltd.
Stock Symbol: BWAY
Market: NYSE
Website: brainsway.com
Menu
BWAY BWAY Quote BWAY Short BWAY News BWAY Articles BWAY Message Board
Get BWAY Alerts

News, Short Squeeze, Breakout and More Instantly...
BWAY - BrainsWay Announces Private Insurance Coverage from Premera Blue Cross for the Treatment of OCD Utilizing Deep TMS(TM)

BURLINGTON, Mass. and JERUSALEM, Nov. 03, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that Preme...
BWAY - BrainsWay to Report Third Quarter Financial Results on November 16, 2022

BURLINGTON, Mass. and JERUSALEM, Nov. 02, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it wi...

BWAY - BrainsWay Appoints Dr. Colleen A. Hanlon as Vice President of Medical Affairs

BURLINGTON, Mass. and JERUSALEM, Nov. 01, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the appoin...

BWAY - BrainsWay Launches Social Media Sweepstakes in Observance of Depression Awareness Month

BURLINGTON, Mass. and JERUSALEM, Oct. 12, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders, today announced the launch of its nationw...
BWAY - BrainsWay and NOCD Launch Collaboration to Increase Awareness of OCD Treatments

BURLINGTON, Mass. and JERUSALEM, Oct. 11, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced th...

BWAY - BrainsWay CEO Christopher von Jako Named Honorary Chair of NAMIWalks Silicon Valley

BURLINGTON, Mass. and JERUSALEM, Sept. 20, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and noninvasive treatment for brain disorders, announced that its President and CEO, Christophe...

BWAY - BrainsWay gets significant private insurance coverage from Cigna for OCD treatment Utilizing Deep TMS

BrainsWay ( NASDAQ: BWAY ) announced that Cigna announced positive coverage applicable to Deep Transcranial Magnetic Stimulation (or TMS) for the treatment of obsessive-compulsive disorder (or OCD). Cigna will be issuing an updated revision to its TMS medical coverage poli...
BWAY - BrainsWay Announces Significant Private Insurance Coverage from Cigna Corporation for the Treatment of OCD Utilizing Deep TMS(TM)

BURLINGTON, Mass. and JERUSALEM, Israel, Sept. 14, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced t...

BWAY - BrainsWay to Present at the H.C. Wainwright Annual Global Investment Conference

BURLINGTON, Mass. and JERUSALEM, Aug. 31, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced and non-invasive treatment for brain disorders, today announced that Christopher von Jako, Ph.D...

BWAY - BrainsWay Ltd.'s (BWAY) CEO Christopher von Jako on Q2 2022 Results - Earnings Call Transcript

BrainsWay Ltd. (BWAY) Q2 2022 Earnings Conference Call August 10, 2022 8:30 AM ET Company Participants Bob Yedid – LifeSci Advisors Christopher von Jako – President and Chief Executive Officer Scott Areglado – Chief Financial Officer Co...
Previous 10 Next 10